STAT-Dx is focused on the development of near-patient testing products for healthcare professionals.
STAT-Diagnostica focuses in the development of near-patient testing products for healthcare professionals, mainly for short turnaround time applications and critical care.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Apr 10, 2016 | Series C | €25M | 8 | Gilde Healthcare | — | Detail |
May 6, 2013 | Series B | €22.10M | 5 | Kurma Partners | — | Detail |
Jun 16, 2011 | Series A | €2M | 1 | Ysios Capital | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Gilde Healthcare | Yes | Series C |
AXIS Telekom | — | Series C |
Boehringer Ingelheim Venture Fund | — | Series C |
Caixa Capital Risc | — | Series C |
Idinvest Partners | — | Series C |
Kurma Partners | — | Series C |
Next47 | — | Series C |
Ysios Capital | — | Series C |